Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANI Pharmaceuticals

64.26
-0.0900-0.14%
Post-market: 64.260.00000.00%16:44 EDT
Volume:519.76K
Turnover:33.48M
Market Cap:1.40B
PE:-140.82
High:65.51
Open:63.45
Low:63.03
Close:64.35
Loading ...

Company Profile

Company Name:
ANI Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
2001
Employees:
897
Office Location:
210 Main Street West,Baudette,Minnesota,United States
Zip Code:
56623
Fax:
218 634 3540
Introduction:
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Directors

Name
Position
Arthur S. Przybyl
President, Chief Executive Officer and Director
Daniel Raynor
Director
Fred Holubow
Director
Peter A. Lankau
Director
Robert E. Brown, Jr.
Director
Thomas A. Penn
Director
Tracy L. Marshbanks
Director

Shareholders

Name
Position
Arthur S. Przybyl
President, Chief Executive Officer and Director
Charlotte C. Arnold
Vice President and Chief Financial Officer
James G. Marken
Vice President, Operations
Robert Schrepfer
Vice President of New Business Development and Contract Manufacturing